Retatrutide is an injectable triple agonist that targets GIP (glucose-dependent insulinotropic polypeptide), GLP-1, and glucagon receptors (GCG receptors) simultaneously
10.1172/JCI119686 41 MaierM
Most common side effects of retatrutide The most commonly reported side effects from retatrutide clinical research are digestive issues, including: Nausea Diarrhoea Vomiting Constipation These are similar to Wegovy's side effects and those seen with Mounjaro
Belcher has since been accused of engaging in widespread fraud by former Chief Science Officer Darren Rubin, in a whistleblower suit filed in 2020
The study findings have not gone through peer reviews yet, and federal regulators with the U.S
For many people with obesity, GLP-1 medications combined with lifestyle changes lead to significantly greater and more sustainable weight loss than lifestyle measures alone